Colambda Technologies, Inc.
NCRE · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | 58.98 | -0.10 | 1.99 |
| FCF Yield | -0.01% | 0.00% | -0.00% | -0.13% |
| EV / EBITDA | 392.67 | 565.77 | -421.66 | -763.32 |
| Quality | ||||
| ROIC | 1.47% | -19,348.98% | -1.50% | 0.00% |
| Gross Margin | 12.38% | 0.00% | 9.71% | 0.00% |
| Cash Conversion Ratio | -43.88 | -58.27 | 0.56 | 0.97 |
| Growth | ||||
| Revenue 3-Year CAGR | 2,086,913.97% | 1,560,664.47% | 1,560,664.47% | -100.00% |
| Free Cash Flow Growth | -3,978.20% | 168.40% | 99.72% | -3,591.46% |
| Safety | ||||
| Net Debt / EBITDA | 15.86 | 15.96 | -20.86 | -1.31 |
| Interest Coverage | 11.35 | -926.80 | -64.46 | -30.26 |
| Efficiency | ||||
| Inventory Turnover | 261.62 | 0.00 | -7,545,054,945,054,945.00 | 0.00 |
| Cash Conversion Cycle | 44.00 | 0.00 | 36.38 | 0.00 |